Zhejiang Wecome Pharmaceutical Company Limited (300878.SZ) SHZ

Currency In CNY

AD

Valuation

Market Cap3.62B
Enterprise Value3.66B
P/E Ratio-23.2
PEG Ratio0.6
Price/Sales Ratio21.92
Price/Book Ratio5.41
Enterprise/Revenue22.18
Enterprise/EBITDA-34.64

Fiscal Year

Fiscal YearDecember 31, 2025
Most Recent QuarterMarch 31, 2026

Profitability

Profit Margin-0.96
Operating Margin-0.81
AD

Management Effectiveness

Return On Assets-0.17
Return On Equity-0.22

Income Statement

Revenue225.06M
Revenue/Share1.59
Gross Profit48.22M
EBITDA-138.2M
Net Income-227.34M
Diluted EPS-1.6

Balance Sheet

Total Cash191.9M
Total Cash/Share1.35
Total Debt239.58M
Total Debt/Equity0.26
Current Ratio1.95
Book Value Per Share6.52

Price History

52-Week Change123.19
52-Week High37.11
52-Week Low15.22
Moving Average 50 Days29.86
Moving Average 200 Days27.34

Statistics

Average Volume3.88M
Shares Outstanding142.05M
% Held by InstitutionsN/A

Dividend And Splits

Trailing Annual Dividend Rate0.14
Trailing Annual Dividend Yield0.4
Payout Ratio-0.12
Last Split Factor9:5
Last Split DateJune 17, 2022
AD